首页> 中文期刊> 《中国临床保健杂志 》 >基层医院老年患者抗血小板药物应用分析

基层医院老年患者抗血小板药物应用分析

             

摘要

目的 调查基层医院老年患者抗血小板药物使用情况,分析影响抗血小板药物使用率的相关因素,以了解基层医院老年患者抗血小板治疗的现状.方法 采用现场问卷形式调查患者的基本资料和抗血小板药物使用情况.结果 191例有抗血小板药物适应证老年患者,抗血小板药物总体使用率为70.16%(134/191),其中阿司匹林占67.91%(91/134).抗血小板药物一级预防使用率63.83%(62/94),均使用阿司匹林.75岁以上组抗血小板药物服用率(79.26%)明显高于75岁以下组(63.30%),P<0.05;冠心病组抗血小板药物服用率(79.75%)明显高于无冠心组(63.39%),P<0.05.结论 基层医院抗血小板药物使用现状与心血管疾病一级预防、二级预防指南推荐的均应服用抗血小板药物的要求存在明显的差距.%Objective To investigate the degree and determinants of antiplatelet agents use among elderly patients from community hospital.Methods The baseline characteristics and use of anti-platelet agents of these patients were collected by questionnaire.Results 191 elderly patients were involved,and all of them had the indication of using antiplatelet agents,but only 70.16% (134/191) patients were using antiplatelet agents.Among those patients using antiplatelet agents,67.91% (91/134) used Aspirin.The taking rote of antiplatelet agents in patients at age ≥75years (79.26%) was significant higher than at age < 75 year(63.30%) (P < 0.05).The taking rate of anti-platelet agents in patients with coronary heart disease(79.75%) was significant higher than that in patients without coronary heart disease(63.39%,P < 0.05).Conclusion There is a gap between the application status of antiplatelet agents on community hospital and recommedation of the primary prevention or secondary prevention guidelines for cardiovascular diseases.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号